These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34418166)

  • 1. Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction?
    Johnston DGW; Kirby B; Tobin DJ
    Exp Dermatol; 2021 Oct; 30(10):1554-1568. PubMed ID: 34418166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yin and Yang: A disrupted skin microbiome and an aberrant host immune response in hidradenitis suppurativa.
    Schell SL; Schneider AM; Nelson AM
    Exp Dermatol; 2021 Oct; 30(10):1453-1470. PubMed ID: 34018644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity and microbial dysbiosis in hidradenitis suppurativa - vicious cycle of chronic inflammation.
    Chopra D; Arens RA; Amornpairoj W; Lowes MA; Tomic-Canic M; Strbo N; Lev-Tov H; Pastar I
    Front Immunol; 2022; 13():960488. PubMed ID: 35967376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa.
    Ghias MH; Hyde MJ; Tomalin LE; Morgan BP; Alavi A; Lowes MA; Piguet V
    J Invest Dermatol; 2020 Mar; 140(3):531-536.e1. PubMed ID: 31870626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on pathogenesis of hidradenitis suppurativa.
    Napolitano M; Fabbrocini G; Marasca C; Monfrecola G
    G Ital Dermatol Venereol; 2018 Jun; 153(3 Suppl 2):3-7. PubMed ID: 30468374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis: common pathways between hidradenitis suppurativa and Crohn disease.
    García Martínez FJ; Menchén L
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():13-20. PubMed ID: 28081764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidradenitis suppurativa: a review of cause and treatment.
    Yazdanyar S; Jemec GB
    Curr Opin Infect Dis; 2011 Apr; 24(2):118-23. PubMed ID: 21192260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa.
    Mozeika E; Pilmane M; Nürnberg BM; Jemec GB
    Acta Derm Venereol; 2013 May; 93(3):301-4. PubMed ID: 23096596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa.
    Zouboulis CC; Nogueira da Costa A; Makrantonaki E; Hou XX; Almansouri D; Dudley JT; Edwards H; Readhead B; Balthasar O; Jemec GBE; Bonitsis NG; Nikolakis G; Trebing D; Zouboulis KC; Hossini AM
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):846-861. PubMed ID: 31838778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting dysbiosis in psoriasis, atopic dermatitis, and hidradenitis suppurativa: the gut-skin axis and microbiome-directed therapy.
    Aguwa C; Enwereji N; Santiago S; Hine A; Kels GG; McGee J; Lu J
    Clin Dermatol; 2023; 41(5):640-649. PubMed ID: 37816413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.
    Campione E; Lanna C; Diluvio L; Cannizzaro MV; Grelli S; Galluzzo M; Talamonti M; Annicchiarico-Petruzzelli M; Mancini M; Melino G; Candi E; Schiavone G; Wang Y; Shi Y; Bianchi L
    Cell Cycle; 2020 Feb; 19(3):257-267. PubMed ID: 31905036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa.
    Giamarellos-Bourboulis EJ; Antonopoulou A; Petropoulou C; Mouktaroudi M; Spyridaki E; Baziaka F; Pelekanou A; Giamarellou H; Stavrianeas NG
    Br J Dermatol; 2007 Jan; 156(1):51-6. PubMed ID: 17199566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond antibodies: B cells in Hidradenitis Suppurativa: Bystanders, contributors or therapeutic targets?
    Frew JW; Grand D; Navrazhina K; Krueger JG
    Exp Dermatol; 2020 May; 29(5):509-515. PubMed ID: 32145106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.
    Del Duca E; Morelli P; Bennardo L; Di Raimondo C; Nisticò SP
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome in Hidradenitis Suppurativa-What We Know and Where We Are Heading.
    Świerczewska Z; Lewandowski M; Surowiecka A; Barańska-Rybak W
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating complement into the molecular pathogenesis of Hidradenitis Suppurativa.
    Grand D; Navrazhina K; Frew JW
    Exp Dermatol; 2020 Jan; 29(1):86-92. PubMed ID: 31688984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity.
    Dréno B; Khammari A; Brocard A; Moyse D; Blouin E; Guillet G; Léonard F; Knol AC
    Arch Dermatol; 2012 Feb; 148(2):182-6. PubMed ID: 22004878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriology of hidradenitis suppurativa/acne inversa: A review.
    Nikolakis G; Join-Lambert O; Karagiannidis I; Guet-Revillet H; Zouboulis CC; Nassif A
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S12-8. PubMed ID: 26470608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.
    Vossen ARJV; van der Zee HH; Prens EP
    Front Immunol; 2018; 9():2965. PubMed ID: 30619323
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathophysiology of hidradenitis suppurativa.
    Hoffman LK; Ghias MH; Lowes MA
    Semin Cutan Med Surg; 2017 Jun; 36(2):47-54. PubMed ID: 28538743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.